In the last 50 years a significant global decline in human sperm concentrations of about 1% per year ([@b4-ehp0116-000070]; [@b7-ehp0116-000070]; [@b24-ehp0116-000070]; [@b33-ehp0116-000070]; [@b36-ehp0116-000070]) has been reported in Western countries, although with regional differences ([@b19-ehp0116-000070]; [@b35-ehp0116-000070]). Furthermore, the youngest generations within a single country have been found to have lower sperm counts ([@b2-ehp0116-000070]; [@b4-ehp0116-000070]; [@b38-ehp0116-000070]).

These phenomena may be related to increasing exposures to estrogenic, anti-estrogenic, or antiandrogenic chemicals during critical phases of testicular development ([@b8-ehp0116-000070]; [@b31-ehp0116-000070]; [@b33-ehp0116-000070]). Exposures to poly-chlorinated dibenzo-*p*-dioxins (PCDDs), polychlorinated biphenyls (PCBs), and poly-chlorinated dibenzofurans (PCDFs), which are products and by-products of industrial or combustion processes, have the potential to disrupt multiple endocrine pathways and induce toxic responses. For example, experimental animal data have shown adverse effects in testicular function, including reduced sperm counts and motility, after exposure to 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD) ([@b13-ehp0116-000070]; [@b23-ehp0116-000070]; [@b30-ehp0116-000070]).

The prenatal and perinatal periods are particularly sensitive, and indeed, higher exposure doses are required to produce similar effects in adult animals ([@b8-ehp0116-000070]; [@b30-ehp0116-000070]; [@b37-ehp0116-000070]). No definitive data are available for men, but [@b14-ehp0116-000070] observed alterations in sperm morphology and motility after prenatal exposure to PCBs/PCDFs in the Yucheng cohort, and [@b15-ehp0116-000070] reported a decrease in sperm motility as a consequence of exposure to PCBs and phthalates in adults.

An explosion on 10 July 1976 at a trichlorophenol manufacturing plant near Seveso, Italy ([@b6-ehp0116-000070]; [@b27-ehp0116-000070]) released up to 30 kg of TCDD ([@b10-ehp0116-000070]; [@b28-ehp0116-000070]).

We investigated the relationship between serum TCDD concentrations in 1976 and semen quality and male reproductive hormones 22 years later. The men studied were exposed either during infancy/prepuberty, puberty, or during early adult life.

Materials and Methods
=====================

Participants
------------

A total of 397 Caucasian males (of the eligible 415) from the highly TCDD-contaminated A zone ([@b10-ehp0116-000070]; [@b28-ehp0116-000070]) and from nearby contaminated areas, all of whom were 1--26 years of age in 1976, were invited to participate in the study conducted in 1997--1998 ([Figure 1](#f1-ehp0116-000070){ref-type="fig"}). Frozen serum samples (generally ≤ 1 mL in volume) from blood collected in 1976--1977 from these subjects were available for TCDD measurements.

A total of 372 consecutive healthy volunteer blood donors the same age as the exposed men, but not living in TCDD-contaminated areas (i.e., they were not exposed to TCDD by the Seveso explosion) were also invited to participate ([Figure 1](#f1-ehp0116-000070){ref-type="fig"}). All participants were first screened for any hidden disease by clinical laboratory tests for liver, bone marrow, kidney, and pancreatic functions. All participants with specific diseases or conditions ([Table 1](#t1-ehp0116-000070){ref-type="table"}) were excluded.

The participants completed a questionnaire on health and socioeconomic status and donated blood and semen samples (samples were collected the morning after having been sexually abstinent for at least 3 days). The study protocol was approved by the Institutional Human Subjects Committee. All study participants gave written informed consent.

Laboratory data
---------------

### Semen samples

Participants collected a postmasturbatory semen sample at home. Each sample was transported at approximately body temperature to the Desio Hospital laboratory and kept at 37°C until examination, which occurred within 1 hr after ejaculation and tests were performed in blind by the same two technicians according to the World Health Organization ([@b40-ehp0116-000070]) recommendation. Ejaculate volume was calculated gravimetrically. Sperm motility was assessed at 400× magnification on a microscope heating stage (37°C) in duplicate, and the average value was recorded. Sperm concentration was measured using a Bürker-Türk chamber at phase contrast (400× magnification). Morphology was evaluated by the same observer on 300 Papanicolaou-stained sperm per slide ([@b9-ehp0116-000070]; [@b20-ehp0116-000070]).

### Serum hormone analyses

Fasting blood samples were obtained on the same morning as semen collection. An aliquot of serum was stored at −80°C and analyzed for hormone levels in large batches to reduce interassay variability. Serum 17β-estradiol (E~2~), follicle-stimulating hormone (FSH), inhibin B, and luteinizing hormone (LH) were measured according to established immunofluorimetric methods, and testosterone was measured by radioimmunoassay. Quality control protocols were applied with strict criteria for all tests.

### Serum TCDD measurements

Vials containing 0.6--1.0 mL serum samples stored frozen since 1976--1977 were analyzed for TCDD by isotope-dilution mass spectrometry at the Centers for Disease Control and Prevention ([@b29-ehp0116-000070]). Serum TCDD concentrations (parts per trillion on serum lipid basis) were also determined in samples drawn in 1997--1998 from all individuals whose 1976--1977 serum TCDD value exceeded 15 ppt \[then the "background level" ([@b28-ehp0116-000070])\] and in pooled samples of men from uncontaminated areas to assess the background levels in 1998/2002. The samples with concentrations less than the detection limit were assigned a value half of that limit.

Statistical analyses
--------------------

We established and maintained a general database using SAS software (version 8.2; SAS Institute Inc., Cary, NC, USA). The exposed and comparison groups were divided, according to the developmental stage of the reproductive system ([@b32-ehp0116-000070]), into three 1976 age classes: infancy/prepuberty, puberty, and young adult (1--9, 10--17, and 18--26 years of age, respectively). Sensitivity analyses were performed to test the cutoff among the age groups. Sperm and hormone data were fitted with a general linear model including group, age class, interaction group × age class as terms, and with abstinence length (not considered for hormone analysis), smoking status (total number of cigarettes smoked per day during months of habitual smoking), body mass index (BMI), and chronic exposure to solvents and other toxic substances in the furniture-manufacturing industry as covariates. We applied scale transformations to approximate normal distribution and homoscedasticity: sperm concentration, total sperm count, progressive motile sperm count, and concentrations of E~2~, testosterone, and FSH were log-transformed; semen volume and concentrations of LH and inhibin B were square-root--transformed. Results were expressed as back transformation of least squares means (i.e., the means adjusted for all the terms in the model). Two families of comparisons were considered: "among groups within age-class" and "among age classes within group." According to the Bonferroni principle, a 0.025 comparison-wise risk of type I error ensures a family-wise risk of type I error ≤ 0.05.

Results
=======

The biological and socioeconomic characteristics of the two study groups were similar, except for a higher education level and lower occupation in the furniture-manufacturing industry in the comparison group ([Table 1](#t1-ehp0116-000070){ref-type="table"}). These differences did not affect the comparison between exposed and unexposed groups; the effect of the inclusion of these variables as covariates in the model was negligible.

The incidence of self-reported varicocele or cryptorchidism were not statistically different in the exposed and comparison groups; however, we excluded these men from the analyses.

The 1976 serum TCDD concentrations of eligible men who did and did not participate in the study were similar ([Figure 1](#f1-ehp0116-000070){ref-type="fig"}). The TCDD concentrations ([Figure 2A, 2B](#f2-ehp0116-000070){ref-type="fig"}) were also comparable among exposed age groups. Median serum TCDD levels in 1998 ([Figure 2C, 2D](#f2-ehp0116-000070){ref-type="fig"}) were higher in males exposed in 1976 as adults than in males who were exposed as children. This is in agreement with the much shorter TCDD half-life in children ([@b5-ehp0116-000070]; [@b21-ehp0116-000070]), but this observation did not explain any statistically significant effects.

We assumed that serum TCDD concentrations for the comparison groups were ≤ 15 ppt in 1976--1977 ([@b28-ehp0116-000070]) and \< 6 ppt in 1998/2002 on the basis of serum results for residents of uncontaminated areas around Seveso (Mocarelli P, unpublished data). Because the only dioxin-like chemical involved with the Seveso incident was TCDD, we focused on TCDD for these analyses. If TCDD acts in concert with other dioxin-like chemicals in affecting sperm quality, the total dioxin toxic equivalency (TEQ) should be considered. In nine serum pools from females residing in the uncontaminated area in 1976, [@b11-ehp0116-000070] found an average TEQ of 100 ppt.

TCDD exposure and semen quality
-------------------------------

In 71 men exposed at 1--9 years of age (mean, 6.2 years), serum TCDD concentrations (median, 210 ppt) had a significant effect on semen quality measured 22 years later. Indeed, significant decreases in sperm count (*p* = 0.025), progressive sperm motility (*p* = 0.001), and total number of motile sperm (*p* = 0.01) were observed relative to the comparison group ([Table 2](#t2-ehp0116-000070){ref-type="table"}). Quartile distribution ([Figure 3A, 3C](#f3-ehp0116-000070){ref-type="fig"}) shows that serum TCDD concentrations ≤ 113 ppt (median of first quartile, 68 ppt) adversely affected sperm concentration and total motile sperm count.

In contrast to the observed effects on men exposed at 1--9 years of age, exposure (median TCDD serum concentration, 164 ppt) at 10--17 years of age (mean, 13.2 years) resulted in effects that appeared to be stimulatory to semen parameters ([Table 2](#t2-ehp0116-000070){ref-type="table"} and [Figure 3B, 3D](#f3-ehp0116-000070){ref-type="fig"}).

In 20 men 40--47 years of age who were exposed to TCDD (serum concentration, 15.5--1,310 ppt; median, 123 ppt) at 18--26 years of age (mean, 21.5 years), we found no statistically significant differences for any of the sperm variables compared with the 32 men in the comparison group. Moreover, no trends in these variables were related to different TCDD serum concentrations in 1998. Also, we observed no statistically significant differences for sperm morphology between exposed and comparison groups.

TCDD exposure and hormone levels
--------------------------------

Men exposed to TCDD at 1--9 and 10--17 years of age had lower serum E~2~ concentrations (*p* \< 0.001) and higher serum FSH concentrations (*p* = 0.055 and *p* = 0.038, respectively) than the comparison groups ([Table 2](#t2-ehp0116-000070){ref-type="table"}). We found differences in E~2~ at TCDD concentrations \< 53 ppt ([Figure 3E, 3F](#f3-ehp0116-000070){ref-type="fig"}). In contrast, subjects exposed at 18--26 years of age (mean, 21.5 years) showed no differences in concentrations of E~2~ (*p* = 0.248) or other hormones relative to the comparison group. Exposure status had no effect on testosterone or inhibin B concentrations in any group.

Comparison between TCDD exposure during infancy and during puberty
------------------------------------------------------------------

The semen of men exposed to TCDD at 1--9 years of age presented significantly greater effects relative to their respective comparisons than semen from men exposed at 10--17 years of age ([Table 2](#t2-ehp0116-000070){ref-type="table"}). Indeed, the former group showed statistically significant lower sperm concentrations (*p* = 0.008), total sperm counts (*p* = 0.004), progressive motility (*p* = 0.005), and total motile sperm counts (*p* \< 0.001) than the latter. No statistically significant differences were noted among the comparison groups ([Table 2](#t2-ehp0116-000070){ref-type="table"}).

Discussion
==========

This study on men from Seveso provides evidence of a permanent disruptive effect of TCDD on the human male reproductive system, depending on the age at exposure. Prepubertal children (\< 9 years of age) are very sensitive to TCDD, with a reduction of sperm concentration and motility observed at serum levels \< 68 ppt (equivalent to a body burden of about 12 ng/kg body weight). In contrast, exposure to TCDD during puberty causes an increase of these semen parameters. If men who are first exposed at 1--9 years of age continued to be exposed at 10--17 years of age to higher than background levels, we would expect the effects to balance out. However, this is not the case. One possible explanation is the much shorter TCDD half-life (months, not years) in young children. Therefore, some of the children exposed at 1--9 years of age may have had a low dose of TCDD (\> 15 ppt background level) still present at puberty, which did not determine a stimulatory effect; the other possibility is the presence of a higher dose at puberty, which nevertheless did not produce a stimulatory effect. Therefore, this contributes to the hypothesis of a permanent effect ([@b26-ehp0116-000070]); note the striking differences between men exposed at 1--9 years of age compared with those exposed at 10--17 years as shown in [Table 2](#t2-ehp0116-000070){ref-type="table"}. Indeed, exposure to endocrine-disrupting chemicals during the period when "programming" of the endocrine system is in progress may result in a permanent change of function or sensitivity to stimulatory/inhibitory signals ([@b8-ehp0116-000070]). One consequence of these opposite effects in infancy compared with puberty could be that the action of dioxin and similar pollutants in the general male population is obscured because the two effects could cancel out each other to give an average normal appearance.

However, in both age groups, TCDD exposure results in a significant reduction in serum E~2~ levels in adulthood. It is important to note that the TCDD body burden and serum levels of these men were within background levels for that time period, demonstrating a permanent effect of the original low dose they received ([Figure 2](#f2-ehp0116-000070){ref-type="fig"}). No effect was observed at all when exposure to TCDD occurred during adulthood.

This study has several strengths. First, we have clearly and directly related original exposure levels of the ubiquitous environmental endocrine disruptor TCDD to reproductive outcomes years after exposure. Second, the participants of the study are fully representative of the available eligible population. Third, the TCDD concentrations affecting children, particularly boys, is similar to the maternal TCDD body burden that has been shown to induce a reduction in sperm numbers in adult rats exposed *in utero* and/or during lactation to TCDD ([@b13-ehp0116-000070]; [@b23-ehp0116-000070]; [@b30-ehp0116-000070]; [@b37-ehp0116-000070]) and to serum concentration shown to decrease the sex ratio ([@b25-ehp0116-000070] and [@b26-ehp0116-000070]) in offspring of TCDD-exposed men at Seveso. These serum concentrations are also lower than the concentrations shown at Seveso to induce a slight, nonstatistically significant increased risk of endometriosis ([@b12-ehp0116-000070]) and breast cancer ([@b39-ehp0116-000070]) in women, and developmental dental aberrations in men exposed at ages younger than 5 years ([@b1-ehp0116-000070]).

However, the study may be weak because of sampling problems involving voluntary sperm analysis. A bias, mainly due to low compliance (∼ 20--40%), has been recorded using sampling as a representation of the general population ([@b19-ehp0116-000070]). To deal with such bias, we chose healthy blood donors from a nearby area; this group of men showed a high compliance (∼ 60%) ([Table 1](#t1-ehp0116-000070){ref-type="table"}) and may be considered representative of the general healthy male population. In any case, we were able to overcome a possible bias by the observation of very significant differences between the 22- to 31-year-old and the 32- to 39-year-old exposed groups ([Table 2](#t2-ehp0116-000070){ref-type="table"}), whereas no differences were seen between the equivalent comparison groups.

A possible role of chronic exposure to solvents or other toxic substances used in the furniture-manufacturing industry has been ruled out by similar exposure ([Table 1](#t1-ehp0116-000070){ref-type="table"}) and by multivariate statistical analysis.

Currently, no data directly relate TCDD exposure at a young age with human sperm quality. The only similar data are those on effects of PCBs and phthalates: [@b15-ehp0116-000070] reported a decrease of sperm motility after exposure to PCBs and phthalates as in our case; and [@b14-ehp0116-000070] observed alterations in sperm morphology after prenatal exposure to PCBs/PCDFs (unlike our data) after an incident in Taiwan in 1979. Also, in Taiwan, men exposed to PCBs/PCDFs at 18--30 years of age showed abnormal sperm morphology ([@b16-ehp0116-000070]). These researchers, however, did not measure PCB/PCDF concentrations at exposure and did not show modification in sperm number, as is the case in the present study. This effect, present in experimental animals ([@b30-ehp0116-000070]; [@b37-ehp0116-000070]), could have gone unnoticed because of the absence of exposure data on children in those studies.

Possible explanations
---------------------

The contrasting effects of infant versus pubertal TCDD exposure on sperm count and the lack of effect in adults may have a physiologic explanation related to differences in the hormonal regulation of Sertoli cell proliferation with age ([@b32-ehp0116-000070]).

Final Sertoli cell number is the main determinant (other than abstinence period) of sperm count in men ([@b32-ehp0116-000070]). Proliferation of these cells in humans occurs during three periods: fetal, postnatal (0--8 months of age), and probably prepubertal. Thus, in the present study, a similar exposure during the prepubertal period (average age, 6.2 years) suppresses Sertoli cell number, whereas exposure during the peripubertal period stimulates Sertoli cell number. This differential action may reflect diversities in the mechanisms that regulate Sertoli cell proliferation at these two time points. Androgens may be the primary stimulator of perinatal and prepubertal proliferation ([@b3-ehp0116-000070]), whereas peripubertal proliferation is driven principally by FSH ([@b18-ehp0116-000070]). Differential effects of TCDD on androgen and FSH action in infancy compared with puberty may provide a ready explanation for the observed differences in sperm count.

TCDD and other dioxin-like chemicals produce their effects primarily through the aryl hydrocarbon receptor (AhR). Activation of AhR by dioxin, therefore, could be a mechanism by which androgen action is reduced; this could explain the observed decrease in sperm count in adults who were exposed to TCDD as young children (i.e., when Sertoli cell development is more testosterone dependent). This hypothesis is supported by the observation that *in utero* exposure of human males to maternal smoking causes reduced sperm counts in the offspring at adulthood; this probably is a result of reduced Sertoli cell number ([@b17-ehp0116-000070]; [@b34-ehp0116-000070]) due to the action of polycyclic aromatic hydrocarbons present in cigarette smoke on AhR.

In contrast, when TCDD contamination occurs at puberty, Sertoli cell proliferation is primarily FSH dependent. E~2~ is a potent negative regulator of FSH secretion, and studies have shown that E~2~ suppression of FSH can reduce Sertoli cell proliferation and number ([@b18-ehp0116-000070]).

TCDD-induced reduction of E~2~ levels (and corresponding elevation of FSH levels), as shown in adults exposed during infancy or puberty (present study), may indicate that increased FSH levels during puberty may lead to increased Sertoli cell proliferation, and hence, to higher sperm counts in adulthood. Although a similar change may have occurred in boys exposed during infancy, the effect of FSH on Sertoli cell proliferation at this age may be insignificant and/or it may be counteracted by the negative repercussions related to suppression of androgen action. Exposure to TCDD after puberty (i.e., after completion of the reproductive system) would not modify estrogen concentration or semen quality, which is consistent with our results.

Taken together, our data are consistent with the untested hypothesis that TCDD exposure during sensitive developmental "windows" may affect expression of responsive genes (with or without the effects of estrogens and/or androgens), permanently altering the programming of the primordial germ cells.

The effect of AhR signaling could be stimulatory or inhibitory, depending on the interplay of factors that include the level of dioxin exposure, the period of sensitivity and/or development of the target cells, and the actual level of key regulatory molecules, including the androgen-estrogen balance. It could also explain the lack of effect of TCDD on spermatogenesis of the mature reproductive system and the "normal morphology" of sperm of exposed men.

Conclusions
===========

Our results directly demonstrate a reduction in E~2~ and a permanent effect on semen quality in human males as a result of the disruptive action of low concentrations of TCDD on the endocrine system. This occurs after exposure especially in infancy/prepuberty, less in puberty, and not in adulthood, at levels, until recently, that were seen in the general population of many industrialized countries. Our data could explain, at least in part, the reported reduction ([@b2-ehp0116-000070]; [@b24-ehp0116-000070]; [@b38-ehp0116-000070]) of semen quality of the youngest populations in Western countries. In fact, these data demonstrate that serum concentrations of about 100 TEQ are border limits; however, at these levels, effects on E~2~ concentration and on the developing male reproductive system begin to be produced. Certain human populations, especially children during breast-feeding ([@b22-ehp0116-000070]), may have a total body burden of dioxin-like chemicals close to this limit. Sensitive children can also be affected at lower concentrations; it will be of interest to see if, as a result of public health efforts in decreasing dioxin levels \[from a TEQ level in children in Seveso in 1976 of about 100 ppt ([@b11-ehp0116-000070]) to about 10 ppt in Germany in 2002/2003 ([@b22-ehp0116-000070])\], there will be a reversal in the reported reduction of semen quality. One remaining significant question will be to determine whether *in utero* exposure will affect human sperm quality.
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This study was supported by grant 2896 from Regione Lombardia, Milano, Italy, and by the Centers for Disease Control and Prevention.

![Flow chart of study showing the relationship between eligible men in 1976, participant men in 1998, and the comparison group on the effects of exposure to TCDD at different ages (1--9; 10--17; 18--26 years) on reproductive hormones and semen quality. Values in parentheses indicate the percentage of men respective to the eligible ones.\
***^a^***Median TCDD serum concentration in 1976 (ppt on a serum lipid basis). ***^b^***Very highly exposed men (\> 2,000 ppt) were excluded: 10 men who were 1--9 years old in 1976 and 6 men who were 10--17 years old in 1976, with median serum concentrations of 6,350 ppt and 3,700 ppt, respectively; none of the men exposed at 18--26 years of age was exposed to \> 2,000 ppt TCDD. ***^c^***For information about this group, see [Table 1](#t1-ehp0116-000070){ref-type="table"}. ***^d^***Serum TCDD concentrations for the comparison groups were assumed to be ≤ 15 ppt in 1976 and \< 6 ppt in 1998. ***^e^***Values in parentheses indicate compliance of the comparison group.](ehp0116-000070f1){#f1-ehp0116-000070}

![Box plots showing dioxin concentration on a serum lipid basis (*A,C*) and body burden \[ng/kg body weight (bw); *B,D*\] in the same men in 1976 (*A, B*) and in 1998 (*C, D*). Values shown are median (line within box), 25th and 75th percentiles (bottom and top of box, respectively), and outliers (circles). Whiskers indicate values within 1.5 times the interquartile range (25th--75th percentiles), and values in parentheses indicate number of men. Serum dioxin concentrations in comparison groups were \< 15 ppt in 1976 and \< 6.0 ppt in 1998. Because weight was not available in medical records for most of the subjects, dioxin body burden was mostly derived in 1976 using normal percentile distribution of weight according to age.](ehp0116-000070f2){#f2-ehp0116-000070}

![TCDD quartile distribution (adjusted mean and 95% confidence interval) of sperm concentration (*A, B*), total motile sperm count (*C, D*), and serum E~2~ (*E, F*) for exposed men and of same-age comparison groups \[*A,C,E*; men who were 1--9 years of age in 1976 (22--31 years of age in 1998); *B,D,F*; men who were 10--17 years of age in 1976 (32--39 years of age in 1998). Median concentrations of TCDD quartiles (shown in parentheses) are expressed as parts per trillion on a serum lipid basis in 1976.](ehp0116-000070f3){#f3-ehp0116-000070}

###### 

Characteristics of study participants by age at time of study.

                                                                                       Exposed (*n* = 257)   Comparison (*n* = 372)                                          
  ------------------------------------------------------------------------------------ --------------------- ------------------------ ------------ ------------ ------------ ------------
  Age class (years)                                                                                                                                                          
   At exposure to dioxin in 1976                                                       1--9                  10--17                   18--26                                 
  No. recruited for the study                                                          130                   90                       37           176          136          60
   No. refused                                                                         40                    29                       11           75           52           23
   No. interested                                                                      90                    61                       26           101          84           37
   Percent compliance                                                                  69                    68                       70           57           62           62
  No. excluded from the study (*n*)[a](#tfn1-ehp0116-000070){ref-type="table-fn"}                                                                                            
   Diabetes                                                                            ---                   1                        2            ---          ---          ---
   Epididymitis                                                                        1                     ---                      ---          1            1            ---
   Urological diseases                                                                 1                     1                        ---          1            ---          1
   Vasectomy                                                                           ---                   ---                      2            ---          ---          ---
   Hormonal therapy                                                                    1                     1                        ---          1            ---          ---
   Hyperthyroidism                                                                     ---                   ---                      ---          ---          ---          1
   Varicocele                                                                          9                     6                        1            9            8            3
   Cryptorchidism                                                                      7                     6                        0            6            2            1
   Varicocele and cryptorchidism                                                       0                     2                        1            1            2            0
  Participants (*n*)                                                                   71                    44                       20           82           71           31
   Age \[years (mean ± SD)\]                                                                                                                                                 
    At the time of the test                                                            28.1 ± 2.5            35.0 ± 2.2               43.3 ± 2.2   27.3 ± 2.9   35.5 ± 2.3   43.1 ± 2.3
    At exposure to dioxin in 1976                                                      6.2 ± 2.5             13.2 ± 2.2               21.5 ± 2.2                             
   BMI (%)[b](#tfn2-ehp0116-000070){ref-type="table-fn"}                                                                                                                     
    \< 25                                                                              53.5                  54.5                     45.0         76.8         53.5         41.9
    25--30                                                                             45.1                  40.9                     40.0         20.7         39.4         48.4
    \> 30                                                                              1.4                   4.6                      15.0         2.5          7.1          9.7
   Education level (%)                                                                                                                                                       
    ≤ Middle school                                                                    46.5                  61.4                     70.0         29.3         39.4         51.6
    High school                                                                        46.5                  34.1                     25.0         42.6         43.7         35.5
    University                                                                         4.2                   4.5                      5.0          11.0         16.9         12.9
    Current student                                                                    2.8                   ---                      ---          17.1         ---          ---
   Tobacco use (%)                                                                                                                                                           
    Never                                                                              47.9                  40.9                     40.0         46.3         43.7         32.3
    Former                                                                             25.4                  29.5                     45.0         19.5         23.9         45.2
    Current                                                                                                                                                                  
      ≤ 5 cigarettes/day                                                               1.4                   9.1                      5.0          3.7          ---          ---
     \> 5 cigarettes/day                                                               25.3                  20.5                     10.0         30.5         32.4         22.5
   Maternal smoking during pregnancy (%)                                                                                                                                     
    No                                                                                 77.4                  81.8                     90.0         86.6         81.7         87.1
    Yes                                                                                11.3                  13.6                     10.0         8.5          16.9         ---
    Unknown                                                                            11.3                  4.6                      ---          4.9          1.4          12.9
   Alcohol use (%)                                                                                                                                                           
     ≤ 10 g /day                                                                       18.3                  15.9                     20.0         22.0         31.0         22.6
    11--20 g /day                                                                      2.8                   4.5                      ---          8.5          5.6          3.2
    21--30 g /day                                                                      8.5                   6.9                      ---          6.1          1.4          9.7
    \> 30 g /day                                                                       70.4                  72.7                     80.0         63.4         62.0         64.5
   Employment status (%)                                                                                                                                                     
    Industry                                                                                                                                                                 
     Furniture manufacturing                                                           10.0                  38.6                     20.0         7.3          4.2          6.5
     Other                                                                             45.0                  18.2                     10.0         24.4         18.3         19.4
    Clerks                                                                             23.9                  15.9                     25.0         35.4         28.2         35.5
    School, other                                                                      21.1                  27.3                     45.0         32.9         49.3         38.6
   Exposure to chemical substances (%)[c](#tfn3-ehp0116-000070){ref-type="table-fn"}   69.0                  82.1                     80.0         42.7         49.3         38.7

Excluded for self-reported causes (questionnaire) or because of pathologic results of clinical laboratory tests (aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, C-reactive protein, glucose, creatinine, complete blood cell count and differential, hemoglobin, hepatitis B surface antigen, hepatitis B core antibody, hepatitis C. Urine analysis was performed for all subjects.

kg/m^2^.

Mostly organic solvents, adhesives, paints, colors, and powders (wood, hides, metals).

###### 

Differences in sperm and hormone data between men exposed to TCDD and nonexposed comparison groups by age at time of study (age at dioxin exposure in 1976).

                                                                                                                                                                                            *p-*Value[a](#tfn5-ehp0116-000070){ref-type="table-fn"}                                                                                  
  --------------------------------------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------------- --------------------------------------------------- ------- ------- ---------- -------
  Participants (*n*)                                                                71                                                  44                                                  82                                                        71                                                                             
  TCDD exposure (ppt[b](#tfn6-ehp0116-000070){ref-type="table-fn"} level median)                                                                                                                                                                                                                                                     
   In 1976                                                                          210[c](#tfn7-ehp0116-000070){ref-type="table-fn"}   164[c](#tfn7-ehp0116-000070){ref-type="table-fn"}   ≤15[d](#tfn8-ehp0116-000070){ref-type="table-fn"}         ≤15[d](#tfn8-ehp0116-000070){ref-type="table-fn"}                              
   In 1998                                                                          3.04                                                4.67                                                \< 6.0                                                    \< 6.0                                                                         
  Sperm concentration (10^6^/mL)                                                                                                                                                                                                                                                                          0.025   0.213   0.008      0.817
   Mean[e](#tfn9-ehp0116-000070){ref-type="table-fn"}                               53.6                                                81.9                                                72.5                                                      60.8                                                                           
   Mean ± SD[e](#tfn9-ehp0116-000070){ref-type="table-fn"}                          21.8--131.8                                         37.8--177.9                                         31.7--165.9                                               24.2--152.8                                                                    
   Adjusted mean[e](#tfn9-ehp0116-000070){ref-type="table-fn"}                      48.6                                                87.4                                                67.1                                                      70.5                                                                           
   Adjusted mean ± SE                                                               43.1--54.8                                          74.7--102.3                                         59.4--75.7                                                61.3--81.1                                                                     
  Total sperm count (10^6^)                                                                                                                                                                                                                                                                               0.168   0.042   0.004      0.663
   Mean                                                                             154.6                                               272.0                                               204.4                                                     191.9                                                                          
   Mean ± SD                                                                        55.8--428.2                                         132.3--559.0                                        83.9--498.1                                               62.8--586.0                                                                    
   Adjusted mean                                                                    149.8                                               302.8                                               186.1                                                     206.5                                                                          
   Adjusted mean ± SE                                                               131.5--170.7                                        255.2--359.3                                        163.2--212.3                                              177.3--240.4                                                                   
  Semen volume (mL)                                                                                                                                                                                                                                                                                       0.196   0.179   0.662      0.818
   Mean                                                                             3.17                                                3.48                                                3.06                                                      3.39                                                                           
   Mean ± SD                                                                        1.50--5.46                                          2.12--5.17                                          1.64--4.93                                                1.87--5.36                                                                     
   Adjusted mean                                                                    3.40                                                3.60                                                3.03                                                      3.13                                                                           
   Adjusted mean ± SE                                                               3.16--3.65                                          3.28--3.93                                          2.81--3.27                                                2.86--3.41                                                                     
  Progressive motility (%)[f](#tfn10-ehp0116-000070){ref-type="table-fn"}                                                                                                                                                                                                                                 0.001   0.187   0.005      0.673
   Mean                                                                             33.2                                                41.1                                                40.8                                                      37.4                                                                           
   Mean ± SD                                                                        19.6--46.9                                          28.9--53.3                                          27.3--54.2                                                23.4--51.3                                                                     
   Adjusted mean                                                                    32.4                                                42.1                                                40.0                                                      38.5                                                                           
   Adjusted mean ± SE                                                               30.5--34.3                                          39.6--44.6                                          38.1--41.9                                                36.3--40.7                                                                     
  Total motile sperm count (10^6^)[g](#tfn11-ehp0116-000070){ref-type="table-fn"}                                                                                                                                                                                                                         0.018   0.036   \< 0.001   0.866
   Mean                                                                             44.2                                                105.2                                               77.5                                                      64.9                                                                           
   Mean ± SD                                                                        11.2--174.0                                         40.0--277.0                                         25.6--234.5                                               15.8--267.0                                                                    
   Adjusted mean                                                                    41.8                                                121.9                                               68.4                                                      72.2                                                                           
   Adjusted mean ± SE                                                               35.2--49.7                                          97.2--152.7                                         57.5--81.5                                                59.1--88.3                                                                     
  E~2~ (pmol/L)                                                                                                                                                                                                                                                                                           0.001   0.001   0.350      0.240
   Mean                                                                             76.2                                                74.4                                                95.9                                                      92.9                                                                           
   Mean ± SD                                                                        59.4--97.7                                          54.5--101.6                                         67.1--137.2                                               67.8--127.3                                                                    
   Adjusted mean                                                                    73.5                                                79.3                                                90.3                                                      99.3                                                                           
   Adjusted mean ± SE                                                               70.4--76.8                                          74.8--83.9                                          86.4--94.4                                                94.3--104.5                                                                    
  FSH (IU/L)                                                                                                                                                                                                                                                                                              0.055   0.038   0.384      0.600
   Mean                                                                             3.58                                                4.10                                                2.98                                                      3.20                                                                           
   Mean ± SD                                                                        2.03--6.32                                          2.84--5.93                                          1.68--5.28                                                1.69--6.05                                                                     
   Adjusted mean                                                                    3.58                                                4.06                                                2.98                                                      3.22                                                                           
   Adjusted mean ± SE                                                               3.31--3.87                                          3.66--4.51                                          2.75--3.23                                                2.93--3.53                                                                     
  Testosterone (nmol/L)                                                                                                                                                                                                                                                                                   0.493   0.145   0.515      0.981
   Mean                                                                             16.4                                                14.3                                                17.7                                                      15.2                                                                           
   Mean ± SD                                                                        12.4--21.8                                          10.7--19.0                                          13.6--23.1                                                11.8--19.5                                                                     
   Adjusted mean                                                                    15.9                                                15.3                                                16.4                                                      16.4                                                                           
   Adjusted mean ± SE                                                               15.4--16.5                                          14.6--16.0                                          15.8--17.0                                                15.8--17.1                                                                     
  LH (U/L)                                                                                                                                                                                                                                                                                                0.979   0.009   0.557      0.156
   Mean                                                                             2.71                                                2.15                                                2.79                                                      2.65                                                                           
   Mean ± SD                                                                        1.57--4.16                                          1.28--3.26                                          1.67--4.20                                                1.64--3.90                                                                     
   Adjusted mean                                                                    2.54                                                2.36                                                2.54                                                      2.98                                                                           
   Adjusted mean ± SE                                                               2.38--2.70                                          2.16--2.57                                          2.38--2.71                                                2.78--3.19                                                                     
  Inhibin B (pg/mL)                                                                                                                                                                                                                                                                                       0.527   0.227   0.640      0.321
   Mean                                                                             118.4                                               116.8                                               117.7                                                     109.5                                                                          
   Mean ± SD                                                                        74.8--172.0                                         78.9--162.2                                         74.3--171.1                                               56.8--179.2                                                                    
   Adjusted mean                                                                    123.4                                               117.1                                               117.8                                                     104.8                                                                          
   Adjusted mean ± SE                                                               116.0--131.1                                        107.7--126.9                                        110.5--125.3                                              96.9--113.0                                                                    

Abbreviations: CG, comparison group; EG, exposed group. Threshold for significance (α= 0.05) is 0.025.

*p-*Values refer to differences adjusted by smoking status (total number of cigarettes per day during months of habitual smoking), chemical substances (mostly organic solvents, adhesives, paints, colors, wood, hides, or metal powders), age at the time of tests, BMI, alcohol use (g/day), education level, employment status, and abstinence time (days) for sperm data. Hormone data were not adjusted for education level, employment status, and abstinence time.

Serum lipid basis.

Ranges of serum TCDD concentrations in 1976 and 1998 are shown in [Figure 2](#f2-ehp0116-000070){ref-type="fig"}.

Dioxin level in comparison groups was obtained from pools of sera from people living in uncontaminated areas.

Values derived from back-transformation of log (sperm concentration, total sperm count, total motile sperm count, E~2~, testosterone, and FSH) and square-root transformation (semen volume, LH, and inhibin B); adjusted as described above. Normal values fall inside this range.

Considered as A + B progressive motility of sperm, according to the [@b40-ehp0116-000070].

Considered as A + B progressive motility of sperm per total sperm count, according to the [@b40-ehp0116-000070].
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